ACO Name & Location
Emergent ACO, LLC
2323 N. John B Dennis Hwy
Kingsport, TN 37660
ACO Primary Contact
Primary Contact Name: Scott R. Fowler, J.D., M.D.
Primary Contact Phone: 423-857-2091
Primary Contact Email: scott.fowler@myhmg.com
Organizational Information
ACO Participants:
| ACO Participants | ACO Participant in Joint Venture (Enter Y or N) |
|---|---|
| Holston Medical Group, PC | Y |
| HealthStar Physicians, PC | Y |
| Iredell Physician Network, LLC | Y |
| RDMG Associates, PA | Y |
| Raleigh Durham Medical Group, PA | Y |
| Samina Yousuf, MD, PC | Y |
| Lieb Family Practice Inc | Y |
| Optimed Hospitalists | Y |
| Medical Care, PLLC | Y |
| Family Practice Associates of Taos | Y |
| La Familia Primary Care PC | Y |
| Schreiber Family Medicine LLC | Y |
| South Central Colfax County Special Hospital District | Y |
| Taos Medical Group PA | Y |
| Taos Whole Health Integrative Care LLC | Y |
| LifeCare Family Medicine of Bellevue, PC | Y |
PY 2025
| Member | Member's Voting Power – Expressed as a Percentage or Number |
Membership Type | ACO Participant Legal Business Name/DBA, if Applicable |
||
|---|---|---|---|---|---|
| Last Name | First Name | Title/Position | |||
| Fowler, J.D., M.D. | Scott | Director/President | 6.25% | ACO Participant Representative | Holston Medical Group, PC |
| Hager, M.D. | Shelton | Director | 6.25% | ACO Participant Representative | Holston Medical Group, PC |
| Moye | David | Director | 6.25% | ACO Participant Representative | RDMG Associates, PA |
| Wenzlik, M.D. | Adam | Director | 6.25% | ACO Participant Representative | RDMG Associates, PA |
| Delay, M.D. | Eric | Director | 6.25% | ACO Participant Representative | HealthStar Physicians, PC |
| McNabney, M.D. | David | Director | 6.25% | ACO Participant Representative | HealthStar Physicians, PC |
| Tondo, M.D. | Lewis | Director | 6.25% | ACO Participant Representative | Iredell Physician Network, LLC |
| Green | John | Director | 6.25% | ACO Participant Representative | Iredell Physician Network, LLC |
| Ajjan, M.D. | Madhi | Director | 6.25% | ACO Participant Representative | Optimed Hospitalists |
| Ibanez, PA | Alicia | Director | 6.25% | ACO Participant Representative | Optimed Hospitalists |
| Hopland, M.D. | Kenneth | Director | 6.25% | ACO Participant Representative | Medical Care, PLLC |
| Hopland | Steve | Director | 6.25% | ACO Participant Representative | Medical Care, PLLC |
| Kauffman, M.D. | Michael | Director | 6.25% | ACO Participant Representative | Taos Medical Group, PA |
| Friedman, M.D. | Neal | Director | 6.25% | Medicare Beneficiary Representative | Medicare Beneficiary Representative |
| Blanken | Vickey | Director | 6.25% | Community Stakeholder | Highlands Physicians, Inc. |
| Sizemore | Samantha | Director | 6.25% | Other | OnePartner Health Solutions, LLC |
| ACO Executive: | Scott R. Fowler, J.D., M.D. |
| Medical Director: | Shelton L. Hager, M.D. |
| Compliance Officer: | Cheryl Stanski, M.D. |
| Quality Assurance/Improvement Officer: | Samantha Sizemore, COO |
| Committee Name | Committee Leader Name and Position |
|---|---|
| Clinical Transformation Committee | Shelton Hager, M.D. - Committee Chair |
| Operations, Quality, Clinical Process, and Population Health Improvement Committee | Samantha Sizemore, COO - Committee Chair |
| Beneficiary Engagement Committee | Samantha Sizemore, COO - Committee Chair |
| Communications & Marketing Committee | Samantha Sizemore, COO - Committee Chair |
| Technology & Data Analytics Committee | Byron Salyer - Committee Chair |
| Contracting & Finance Committee | Shawna Armstrong, Treasurer - Committee Chair |
| Compliance Committee | Cheryl Stanski, M.D. - Committee Chair |
Types of ACO Participants, or Combinations of Participants, that Formed the ACO:
- Networks of individual practices of ACO professionals
Shared Savings and Losses
- Second Agreement Period
- Performance Year 2026 – N/A
- Performance Year 2025 – N/A
- First Agreement Period
- Performance Year 2024 - $12,489,314.95
- Performance Year 2023 - $13,329,960.66
- Performance Year 2022 - $10,221,401.17
- Performance Year 2021 - $8,290,400.71
- Performance Year 2020 - $8,679,219.81
- Performance Year 2019 - $3,289,869.51
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019, therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
- Second Agreement Period
- Performance Year 2026
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2025
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2026
- First Agreement Period
- Performance Year 2024
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2023
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 75%
- Performance Year 2022
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2021
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2020
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 20%
- Proportion of distribution to ACO participants: 80%
- Performance Year 2019
- Proportion invested in infrastructure: 0%
- Proportion invested in redesigned care processes/resources: 0%
- Proportion of distribution to ACO participants: 100%
- Performance Year 2024
Note: Our ACO participated in multiple performance years during Calendar Year 2019. Shared savings/losses amount reported for Performance Year 2019, therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Quality Performance Results
2024 Quality Performance Results:
Quality performance results are based on the CMS Web Interface collection type
| Measure # | Measure Name | Collection Type |
Performance Rate |
Current Year Mean Performance Rate (Shared Savings Program ACOs) |
|---|---|---|---|---|
| 321 | CAHPS for MIPS | CAHPS for MIPS Survey | 8.49 | 6.67 |
| 479* | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups | Administrative Claims | 0.1427 | 0.1517 |
| 484 | * Clinician and Clinician Group Risk standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) | Administrative Claims | - | 37 |
| 318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 95.92 | 88.99 |
| 110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 97.69 | 68.6 |
| 226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 100 | 79.98 |
| 113 | Colorectal Cancer Screening | CMS Web Interface | 83.58 | 77.81 |
| 112 | Breast Cancer Screening | CMS Web Interface | 85.64 | 80.93 |
| 438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 84.68 | 86.5 |
| 370 | Depression Remission at Twelve Months | CMS Web Interface | 25 | 17.35 |
| 001* | Diabetes: Hemoglobin A1c (HbA1c) Poor Control | CMS Web Interface | 9.42 | 9.44 |
| 134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 92.19 | 81.46 |
| 236 | Controlling High Blood Pressure | CMS Web Interface | 87.57 | 79.49 |
| CAHPS -1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 87.57 | 83.70 |
| CAHPS -2 | How Well Providers Communicate | CAHPS for MIPS Survey | 94.85 | 93.96 |
| CAHPS -3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 91.83 | 92.43 |
| CAHPS -4 | Access to Specialists | CAHPS for MIPS Survey | 77.35 | 75.76 |
| CAHPS -5 | Health Promotion and Education | CAHPS for MIPS Survey | 65.41 | 65.48 |
| CAHPS - 6 | Shared Decision Making | CAHPS for MIPS Survey | 67.78 | 62.31 |
| CAHPS -7 | Health Status and Functional Status | CAHPS for MIPS Survey | 75.7 | 74.14 |
| CAHPS -8 | Care Coordination | CAHPS for MIPS Survey | 87.83 | 85.89 |
| CAHPS - 9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 94.55 | 92.89 |
| CAHPS -11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 28.85 | 26.98 |
For previous years’ Financial and Quality Performance Results, please visit: Data.cms.gov
*For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
*For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.
Payment Rule Waivers
- Waiver for Payment for Telehealth Services:
- Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
- Fraud and Abuse Waivers
- ACO Pre-Participation Waiver:
The following information describes each arrangement for which our ACO seeks protection under the ACO
Pre-Participation Waiver, including any material amendment or modification to a disclosed arrangement.- Parties to the arrangement: Emergent ACO, LLC and Quest Diagnostics, Inc.
- Date of arrangement: 03/16/2018
- Items, services, goods, or facility provided: Services
- No Amendments
- Summary of Arrangement Conducted Under the Medicare ACO Pre-Participation Waiver
- ACO Participation Waiver:
The following information describes each arrangement for which our ACO seeks protection under the ACO
Participation Waiver, including any material amendment or modification to a disclosed arrangement.- Parties to the arrangement: Emergent ACO, LLC and Quest Diagnostics, Inc.
- Date of arrangement: 02/01/2019
- Items, services, goods, or facility provided: Services
- No Amendments
- Summary of Arrangement Conducted Under the Medicare ACO Participation Waiver
- ACO Pre-Participation Waiver:
Last updated on February 16, 2026